<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

News and Stories

Research

Research    COVID-19

Calming the Inflammation Storm to Protect the Lungs in COVID-19

If COVID-19 is a fire, the damaging cycle of inflammation known as a ‘cytokine storm’ is the tsunami that fans the blaze while flattening the rest of the village.


Author Guest Contributor | Publish Date April 15, 2020
Full Story

Research    COVID-19

CU Doctors Work to Treat COVID-19, Now and in the Future

Probably the hardest part of his job caring for patients stricken with a virus doctors know little about is the forced isolation: watching them battle for their lives with no loved ones by their sides.


Author Debra Melani | Publish Date April 09, 2020
Full Story

Research    COVID-19 Podcasts

Research Could Lead to New Therapeutic Options for Lymphedema Patients

Thanks to a somewhat unexpected research journey, Tamara Terzian, PhD, and her team recently uncovered a new molecular pathway to a previously untreatable and common lymphatic disease, lymphedema. Terzian explains how the establishment of a lymphatic club on the CU Anschutz Medical Campus – involving Beth Tamburini, PhD, assistant professor of medicine and immunology, and Traci Lyons, PhD, associate professor of medicine-medical oncology – helped to advance her team’s significant findings.


Author Chris Casey | Publish Date April 02, 2020
Full Story

Research

Researchers Have ‘Eureka’ Moment When Studying Molecule’s Role in Lymphedema

Tamara Terzian, PhD, a dermatology professor and researcher in the University of Colorado Cancer Center, focuses much of her research on genetic pathways that underlie diseases of the skin, such as pigmentary disorders and melanoma. Of particular interest in these diseases is the role of the tumor-suppressor molecule p53.


Author Chris Casey | Publish Date April 02, 2020
Full Story

Research    Patient Care    COVID-19

Clinical Trial for Patients Hospitalized With COVID-19 Opens at CU Anschutz

On March 25, Thomas Campbell, MD, was in an intensive care unit where a critically ill patient hospitalized with severe COVID-19 was to be the first given an experimental treatment at the University of Colorado Anschutz Medical Campus.


Author Shawna Matthews | Publish Date April 01, 2020
Full Story

Research

World Autism Awareness Day 2020

On this year's World Autism Awareness Day, we take a look at some of the innovative autism research happening at the University of Colorado Anschutz Medical Campus. 


Author Staff | Publish Date March 31, 2020
Full Story

Research    Patient Care

This Is Breakthrough: Dr. Dan Pollyea

“AML is usually not eradicated with traditional, conventional chemotherapy,” says Dan Pollyea, MD, MS, Clinical Director of Leukemia Services and associate professor in the Division of Hematology, “and is a source of relapse when it occurs, which historically is pretty much always with this disease.”  


Author Matthew Hastings | Publish Date March 31, 2020
Full Story

Research    Patient Care

Focusing in on Colorectal Cancer: Is 45 the New 50?

Editor's Note: The Senate Committee on Health and Human Services postponed the bill indefinitely after returning from the pandemic shutdown.

A pandemic stole Alba Wilson-Axpe’s chance at the podium recently. But when the Colorado Legislature re-opens its doors to the public, odds are high the 14-year-old will be back to testify.


Author Debra Melani | Publish Date March 26, 2020
Full Story

Research    COVID-19

In COVID-19 Battle, CU Anschutz Team Teaching Old Drugs New Tricks

As scientists around the world scramble against the COVID-19 clock, searching for a vaccine that could stop the viral infection before it happens, a trio of experts on the University of Colorado Anschutz Medical Campus have taken a different tack: overpowering the new mutation after it invades the body.


Author Debra Melani | Publish Date March 23, 2020
Full Story

Research    Patient Care

New Down Syndrome Study Goes Beyond Skin Deep

Patchy bald spots and painful skin lesions are targets of a new clinical trial aimed at curbing common skin conditions in people living with Down syndrome. For trial participants, that success would be benefit enough.


Author Debra Melani | Publish Date March 18, 2020
Full Story